Skip to main content
Frontiers in Neurology logoLink to Frontiers in Neurology
. 2021 Jul 9;12:669174. doi: 10.3389/fneur.2021.669174

Sex Differences in the Association Between Obesity and Cognitive Impairment in a Low-Income Elderly Population in Rural China: A Population-Based Cross-Sectional Study

Dandan Guo 1,, Xin Zhang 1,, Changqing Zhan 1,2,, Qiuxing Lin 1,3,4, Jie Liu 1,3,4, Qiaoxia Yang 5, Jun Tu 1,3,4, Xianjia Ning 1,3,4,*, Jinghua Wang 1,3,4,*, Yijun Song 6,*
PMCID: PMC8299782  PMID: 34305783

Abstract

Background: Obesity is a potentially modifiable risk factor for cognitive impairment. However, sex-specific relationships between obesity and cognitive impairment in late life remain unclear.

Objective: We aimed to assess sex differences in the association between various obesity parameters and cognitive impairment in a low-income elderly population in rural China.

Methods: A population-based cross-sectional study was conducted to collect basic information from elderly residents aged 60 years and older from April 2014 to August 2014 in rural areas of Tianjin, China. Obesity parameters, including body mass index (BMI) and waist circumference (WC), and Mini Mental State Examination scores were measured, and the relationships between these variables were assessed.

Results: A total of 1,081 residents with a mean age of 67.70 years were enrolled in this study. After adjusting for age, educational attainment, smoking status, drinking status, physical exercise participation, and the presence of diabetes and hyperlipidemia, blood pressure group; a high BMI was found to be associated with an increased prevalence of cognitive impairment in elderly women. Each 1-unit increase in BMI was associated with a 5.9% increase in the prevalence of cognitive impairment. WC was related to the prevalence of cognitive impairment in elderly men, and each 1-cm increase in WC was associated with a 4.0% decrease in the prevalence of cognitive impairment. However, there were no significant associations between WC and cognitive function in women or between BMI and cognitive impairment in men.

Conclusion: A greater WC was positively associated with better cognitive function in low-income elderly men in rural China, whereas a higher BMI was associated with an increased risk of cognitive impairment in elderly women, independent of sociodemographic, lifestyle, and health-related comorbid factors. Our results suggest weight management of elderly women in rural China may have cognitive benefits. However, randomized controlled trials would be needed to confirm causality.

Keywords: cognitive impairment, obesity, body mass index, waist circumstance, sex difference

Introduction

Cognitive disorders, including dementia and mild cognitive impairment, have become a global public health priority for aging populations (1, 2). According to the World Alzheimer Report 2019, there were over 50 million people living with dementia globally, and this number is estimated to increase to more than 152 million by 2050 (3). The current annual costs related to dementia worldwide were approximately 1 trillion USD in 2019, a figure set to double by 2030 (3). Moreover, the prevalence of dementia has been increasing rapidly over the past two decades in China, from 2.30 to 6.44%, especially among populations in rural areas with low educational attainment (4, 5). Meanwhile, the prevalence of obesity is also increasing worldwide and has become a global epidemic among older people (6). In China, the overall prevalence of general obesity among adults has increased 3-fold, from 3.3% in 2004 to 14.0% in 2014, posing a huge economic and social burden (7).

Obesity has often been recognized in the literature as a potentially modifiable risk factor for cognitive impairment (8, 9). The effects of obesity on cognitive function appear to vary by age and obesity status. Most of the recent studies have demonstrated that general obesity at midlife was related to an increased risk of cognitive decline in later life, especially for episodic memory and executive function (1012). However, the association between obesity and cognitive impairment in the elderly is unclear. Several studies have demonstrated that general obesity as classified using body mass index (BMI) was associated with a decreased risk of cognitive impairment in the elderly, while abdominal obesity was harmful to cognitive function (1315). In contrast, other studies have reported that both general and abdominal obesity were associated with an increased risk of cognitive dysfunction in old age (16, 17). Furthermore, few studies have reported the sex-related relationships between obesity and cognitive impairment, and these results were inconsistent (1820).

The prevalence of cognitive impairment in rural China is notably higher than that in urban areas (5). However, the relationship between obesity in late life and cognitive impairment remains unclear among low-income populations in rural China. Additionally, sex differences in the associations between obesity and cognitive impairment are not well-known in China. Thus, the aim of this study was to assess the sex differences in the association between obesity and cognitive impairment among a low-income elderly population in rural China.

Methods

Study Population

This was a population-based, cross-sectional study conducted from April 2014 to August 2014 in rural areas of Tianjin, China. The participants were from the Tianjin Brain Study, which has been described previously (21, 22). All residents aged 60 years and older without vision and auditory dysfunction were invited to participate in this study. However, individuals with a history of myocardial infarction, stroke, congenital hypophrenia, and mental illness were excluded from participation.

The study was approved by the ethics committee of Tianjin Medical University General Hospital and conformed to the Declaration of Helsinki regarding the use of human subjects. Written informed consent was obtained from each patient during recruitment.

Risk Factors and Physical Examinations

This study was conducted through face-to-face interviews by a trained research staff. A pre-designed questionnaire was used to collect the following information: demographic information (including name, sex, date of birth, and educational level), individual medical history (including the presence of hypertension, diabetes mellitus, and hyperlipidemia), and lifestyle factors (including smoking, drinking, and physical exercise). A physical examination was performed to obtain information on height, weight, and waist circumference (WC) with subjects wearing thin clothes. BMI was calculated as the individual's weight (kg) divided by the square of the individual's height (m2). Blood pressure (BP) measurements were performed using an electronic sphygmomanometer. Subjects were asked to remain resting in a sitting position for 15 min before testing; BP was measured three times, and the mean was obtained. The levels of fasting blood glucose (FBG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were tested in the central laboratory of Tianjin Ji County People's Hospital. Both the Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scales were used for screening cognitive impairment owing to their high sensitivity and specificity (23). However, considering that the content of the MoCA questionnaire was not suitable for elderly with low education in rural China, the MMSE questionnaire was used to assess cognitive impairment.

Cognitive Impairment Criteria

The diagnostic criteria for cognitive impairment were based on MMSE scores and educational levels. Cognitive impairment was defined as an MMSE score <17 points in the group with no formal schooling, <22 points in the group with a primary school education, and <26 points in the group with a junior school education and above (24).

Definitions

Hypertension was defined as a systolic blood pressure (SBP) ≥ 140 mm Hg, diastolic blood pressure (DBP) ≥ 90 mmHg, the use of antihypertensive drugs, or a history of hypertension. Stage I hypertension was defined as SBP ≥ 140 mm Hg and < 160 mm Hg or DBP ≥ 90 mm Hg and < 100 mm Hg, stage II hypertension was defined as SBP ≥ 160 mm Hg and < 180 mm Hg or DBP ≥ 100 mm Hg and < 110 mm Hg, and stage III hypertension was defined as SBP ≥ 180 mm Hg or DBP ≥ 110 mm Hg. Diabetes was defined as FBG ≥ 7.0 mmol/L, the use of diabetes medication, or a self-reported history of diabetes. Hyperlipidemia was defined as total cholesterol ≥5.18 mmol/L, low-density lipoprotein cholesterol ≥3.37 mmol/L, triglycerides ≥ 1.70 mmol/L, or high-density lipoprotein cholesterol < 1.04 mmol/L, or with diagnosis of hyperlipidemia. General obesity was defined as a BMI ≥ 28.0 kg/m2, and overweight was defined as a BMI ≥ 24.0 kg/m2 and < 28.0 kg/m2. Central obesity was defined as a WC >90 cm for men and >80 cm for women. Besides, BMI and WC were categorized into sex-specific quartiles. For men, first quartile of BMI was defined as <22.23 kg/m2; second quartile was 22.23–24.45 kg/m2; third quartile was 24.46–26.69 kg/m2 and fourth quartile was ≥ 26.70 kg/m2. First quartile of WC in men was defined as < 82 cm; second quartile was 82–87 cm; third quartile was 88–95 cm and fourth quartile was ≥ 96 cm. For women, first quartile of BMI was defined as <22.85 kg/m2; second quartile was 22.85–25.10 kg/m2; third quartile was 25.11–27.58 kg/m2 and fourth quartile was ≥ 27.59 kg/m2. First quartile of WC in women was defined as < 84 cm; second quartile was 84–88 cm; third quartile was 89–94 cm and fourth quartile was ≥95 cm. Smoking was defined as smoking ≥ 1 cigarette daily for more than 1 year. Drinking was defined as drinking >50 mL of alcohol at least once per week for more than 6 months.

Statistical Analysis

Continuous variables are summarized as means and standard deviations; Student's t-test was used to compare the differences between the two groups. Categorical variables are summarized as numbers with frequencies; the chi-square test was performed to compare the differences between the two groups. The participants were categorized into four age groups (60–64, 65–69, 70–74, and ≥75 years), three educational groups according to the length of formal education (0–5, 6–8, and ≥9 years), and four BP groups (normal, stage I hypertension, stage II hypertension, and stage III hypertension). Multiple logistic regression analyses were used to evaluate the relationship between BMI or WC (continuous variables) and cognitive impairment by sex. Independent variables in the multivariate analyses were those factors found to be significant in the univariate analyses. Box-Tidwell method (25) was used to test linear relationship between continuous independent variables (BMI/WC) and dependent variable logit conversion values (all P > 0.05). Thus, BMI and WC were considered as continuous variables in multiple logistic regression analyses. Moreover, BMI and WC were also evaluated as categorical variables in multiple logistic regression analyses, divided by sex-specific quartiles. BMI and WC were included in different equations separately because of their high collinearity.

The multivariate analysis results are presented as adjusted odds ratios (ORs) and 95% confidence intervals (CIs) after adjusting for covariates. Additionally, three logistic regression models were developed to examine the associations of BMI and WC with cognitive impairment by sex. Model 1 involved adjusting for age and educational level (categorical variables). Model 2 was based on Model 1 and additionally adjusted for lifestyle factors (smoking, drinking, and physical exercise). Model 3 was based on Model 2 and additionally adjusted for BP group, diabetes, and hyperlipidemia.

All statistical analyses were performed with SPSS version 25.0 statistical software (SPSS Inc., Chicago, IL), and a two-sided P-value < 0.05 was considered statistically significant.

Results

Demographic Characteristics

A total of 1,081 residents aged 60 years and older were enrolled in this study. There were 500 men (46.3%) and 581 women (53.7%), with a mean age of 67.70 years overall (67.96 years for men and 67.47 years for women). In this rural population, the prevalence of cognitive impairment was 33.2% overall (26.6% in men and 38.9% in women). Moreover, there was a higher prevalence of central and general obesity in women than in men (88.1 vs. 44.0% and 22.5 vs. 16.2%, respectively; both P < 0.01) among residents with cognitive impairment. In this population, women were more likely to have lower educational attainment and MMSE scores and higher BMI, DBP, FBG, TC, TG, HDL, and LDL levels than men (P < 0.05) (Table 1).

Table 1.

Demographic characteristics and risk factors for all participants by sex group.

Risk factors Men Women Total P
Total, n (%) 500 (46.3) 581 (53.7) 1081 (100)
Age, means (SD) 67.96 (6.42) 67.47 (6.48) 67.70 (6.46) 0.209
Age group, n (%) 0.201
   60–64 years 190 (38.0) 249 (42.9) 438 (40.6)
   65–69 years 138 (27.6) 157 (27.0) 295 (27.3)
   70–74 years 82 (16.4) 72 (12.4) 155 (14.2)
   ≥75 years 90 (18.0) 103 (17.7) 193 (17.9)
Education, years, mean (SD) 5.35 (2.72) 2.62 (2.94) 3.88 (3.15) <0.001
Education, n (%) <0.001
   0–5 years 203 (40.6) 451 (77.6) 654 (60.5)
   6–8 years 219 (43.8) 101 (17.4) 320 (29.6)
   ≥9 years 78 (15.6) 29 (5.0) 107 (9.9)
Smoking, n (%) <0.001
   No 136 (27.2) 261 (44.9) 397 (36.7)
   Yes 364 (72.8) 320 (55.1) 684 (63.3)
Drinking, n (%) <0.001
   No 280 (56.0) 492 (84.7) 772 (71.4)
   Yes 220 (44.0) 89 (15.3) 309 (28.6)
Physical exercise, n (%) 0.779
   No 429 (85.8) 495 (85.2) 924 (85.5)
   Yes 71 (45.2) 86 (14.8) 157 (14.5)
Hypertension, n (%) 0.568
   No 106 (21.2) 115 (19.8) 221 (20.4)
   Yes 394 (78.8) 466 (80.2) 860 (79.6)
Diabetes, n (%) 0.012
   No 432 (86.4) 469 (80.7) 901 (83.3)
   Yes 68 (13.6) 112 (19.3) 180 (16.7)
Hyperlipidemia, n (%) <0.001
   No 258 (51.9) 190 (32.9) 448 (41.7)
   Yes 239 (48.1) 388 (67.1) 627 (58.3)
BP group, n (%) 0.934
   Normal 127 (25.4) 144 (24.8) 271 (25.1)
   Stage I HBP 176 (35.2) 199 (34.3) 375 (34.7)
   Stage II HBP 118 (44.5) 147 (25.3) 265 (24.5)
   Stage III HBP 79 (15.8) 91 (15.7) 170 (15.7)
BMI (kg/m2), mean (SD) 24.59 (3.31) 25.21 (3.57) 24.92 (3.46) 0.004
BMI category (kg/m2), n (%) 0.009
   Normal 220 (44.0) 212 (36.5) 432 (40.0)
   Overweight 199 (39.8) 238 (41.0) 437 (40.4)
   Obese 81 (16.2) 131 (22.5) 212 (19.6)
Waist (cm), mean (SD) 88.58 (9.29) 89.21 (8.68) 88.92 (8.97) 0.250
Central obesity, n (%) <0.001
   No 280 (56.0) 69 (11.9) 349 (32.3)
   Yes 220 (44.0) 512 (88.1) 732 (67.7)
MMSE score, mean (SD) 22.30 (4.54) 19.13 (5.31) 20.60 (5.21) <0.001
MMSE group, n (%) <0.001
   Non-CI 367 (73.4) 355 (61.1) 722 (66.8)
   CI 133 (26.6) 226 (38.9) 359 (33.2)
SBP, mean (SD) 153.66 (23.06) 154.95 (23.28) 154.35 (23.18) 0.360
DBP, mean (SD) 87.05 (11.53) 85.52 (11.76) 86.23 (11.67) 0.031
FBG, mean (SD) 5.84 (1.18) 6.18 (1.93) 6.02 (1.64) 0.001
TC, mean (SD) 4.56 (0.95) 5.18 (1.07) 4.89 (1.06) <0.001
TG, mean (SD) 1.41 (0.83) 1.82 (1.29) 1.63 (1.12) <0.001
HDL, mean (SD) 1.42 (0.44) 1.53 (0.47) 1.48 (0.46) <0.001
LDL, mean (SD) 2.49 (0.79) 2.85 (0.90) 2.68 (0.87) <0.001

SD, standard deviation; BP, blood pressure; BMI, body mass index; MMSE, Mini-Mental state examination; CI, cognitive impairment; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.

Associations of Cognitive Impairment With Risk Factors by Sex in the Univariate Analysis

For elderly men, cognitive impairment was associated with older age, lower educational attainment, and higher SBP. Moreover, WC and were associated with cognitive impairment in men. The prevalence of cognitive impairment in men with central obesity was lower than that without central obesity (Table 2).

Table 2.

Association of cognitive impairment with demographic characteristics and risk factors by gender in univariate analysis.

Characteristics Male Female
Non-CI CI P Non-CI CI P
Age, means (SD) 66.89 (5.71) 70.92 (7.31) <0.001 66.04 (5.36) 69.71 (7.41) <0.001
Age group, n (%) <0.001 <0.001
   60–64 years 158 (83.2) 32 (16.8) 175 (70.3) 74 (29.7)
   65–69 years 107 (77.5) 31 (22.5) 105 (66.9) 52 (33.1)
   70–74 years 54 (65.9) 28 (34.1) 42 (58.3) 30 (41.7)
   ≥75 years 48 (53.3) 42 (46.7) 33 (32.0) 70 (68.0)
Education, years, mean (SD) 5.64 (2.57) 4.55 (2.97) <0.001 3.43 (2.99) 1.34 (2.36) <0.001
Education, n (%) <0.001 <0.001
   0–5 years 128 (63.1) 75 (36.9) 247 (54.8) 204 (45.2)
   6–8 years 180 (82.2) 39 (17.8) 84 (83.2) 17 (16.8)
   ≥9 years 59 (75.6) 19 (24.4) 24 (82.8) 65 (17.2)
Smoking, n (%) 0.121 0.672
   No 93 (68.4) 274 (31.6) 157 (60.2) 104 (39.8)
   Yes 274 (75.3) 90 (24.7) 198 (61.9) 122 (38.1)
Drinking, n (%) 0.922 0.536
   No 206 (73.6) 74 (26.4) 298 (60.6) 194 (39.4)
   Yes 161 (73.2) 59 (26.8) 57 (64.0) 32 (36.0)
Physical exercise, n (%) 0.584 0.542
   No 313 (73.0) 116 (27.0) 305 (61.6) 190 (38.4)
   Yes 54 (76.1) 17 (23.9) 50 (58.1) 36 (41.9)
Hypertension, n (%) 0.125 0.221
   No 84 (79.2) 22 (20.8) 76 (66.1) 39 (33.9)
   Yes 283 (71.8) 111 (28.2) 279 (59.9) 187 (40.1)
Diabetes, n (%) 0.081 0.325
   No 323 (74.0) 109 (26.0) 282 (60.1) 187 (39.9)
   Yes 44 (74.8) 24 (25.2) 73 (65.2) 39 (34.8)
Hyperlipidemia, n (%) 0.220 0.908
   No 195 (75.6) 63 (24.4) 117 (61.6) 73 (38.4)
   Yes 169 (70.7) 70 (29.3) 237 (61.1) 151 (38.9)
BP group, n (%) 0.024 0.007
   Normal 97 (77.0) 30 (23.0) 96 (66.7) 48 (33.3)
   Stage I HBP 135 (78.6) 41 (21.4) 129 (64.8) 70 (35.2)
   Stage II HBP 88 (74.4) 30 (25.6) 83 (56.5) 64 (43.5)
   Stage III HBP 47 (60.2) 32 (39.8) 47 (51.6) 44 (48.4)
BMI (kg/m2), mean (SD) 24.88 (3.25) 24.10 (3.43) 0.047 25.18 (3.53) 25.25 (3.63) 0.797
BMI category, n (%) 0.064 0.962
   Normal 150 (69.0) 70 (31.0) 131 (61.8) 81 (38.2)
   Overweight 154 (79.2) 45 (20.8) 144 (60.5) 94 (39.5)
   Obese 63 (76.7) 18 (23.3) 80 (61.1) 51 (38.9)
Waist (cm), mean (SD) 89.14 (9.26) 87.04 (9.25) 0.025 89.96 (9.00) 89.61 (8.15) 0.379
Central obesity, n (%) 0.006 0.124
   No 192 (68.6) 88 (31.4) 48 (69.6) 21 (30.4)
   Yes 175 (79.5) 45 (20.5) 307 (60.0) 205 (40.0)
SBP, mean (SD) 152.27 (22.40) 157.49 (24.47) 0.025 152.95 (22.13) 158.10 (24.71) 0.009
DBP, mean (SD) 87.14 (10.91) 86.80 (13.12) 0.790 85.38 (11.41) 85.73 (12.31) 0.729
FBG, mean (SD) 5.79 (1.15) 6.01 (1.26) 0.064 6.23 (2.05) 6.11 (1.74) 0.467
TC, mean (SD) 4.55 (0.97) 4.57 (0.92) 0.812 5.15 (1.06) 5.20 (1.06) 0.400
TG, mean (SD) 1.42 (0.83) 1.41 (0.85) 0.790 1.86 (1.45) 1.75 (0.97) 0.346
HDL, mean (SD) 1.41 (0.42) 1.44 (0.49) 0.535 1.51 (0.44) 1.56 (0.50) 0.184
LDL, mean (SD) 2.49 (0.82) 2.48 (0.73) 0.883 2.84 (0.91) 2.87 (0.90) 0.699
MMSE score, mean (SD) 24.32 (2.69) 16.71 (3.87) <0.001 22.50 (3.20) 13.85 (3.27) <0.001

SD, standard deviation; BP: blood pressure; BMI, body mass index; MMSE, Mini-Mental state examination; CI: cognitive impairment; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG: fasting blood glucose; TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.

For elderly women, cognitive impairment was associated with older age, lower educational attainment, and higher SBP. However, neither BMI nor WC was associated with cognitive impairment in women (Table 2).

Associations of BMI and WC With Cognitive Impairment by Sex and Age in the Multivariate Analysis

For elderly men, there was no significant association between BMI and cognitive impairment after adjusting for age, educational level, and BP group. WC was associated with cognitive impairment in elderly men, and each 1-cm increase in WC was associated with a 3% decrease in the prevalence of cognitive impairment after adjusting for age, educational level, and BP group (95% CI 0.95–0.99; P = 0.013). In a subgroup analysis, the association remained consistent among men aged 60–64 years and each 1-cm increase in WC was associated with a 5% decrease in the prevalence of cognitive impairment (95% CI 0.91–0.99; P = 0.042) (Table 3).

Table 3.

Association of BMI and waist circumference with cognitive impairment by age groups among elderly men in the multivariate analysis.

Factors OR (95% CI) P
BMI
All male participantsa 0.95 (0.89, 1.02) 0.129
Age group
   60–64 yearsb 0.90 (0.79, 1.03) 0.125
   65–69 yearsb 1.00 (0.88, 1.14) 0.981
   70–74 yearsb 0.97 (0.89, 1.13) 0.691
   ≥75 yearsb 0.95 (0.82, 1.09) 0.459
Waist circumference
All male participantsa 0.97 (0.95, 0.99) 0.013
Age group
   60–64 yearsb 0.95 (0.91, 0.99) 0.042
   65–69 yearsb 1.00 (0.96, 1.04) 0.942
   70–74 yearsb 0.97 (0.92, 1.03) 0.270
   ≥75 yearsb 0.96 (0.91, 1.02) 0.161
a

Adjusting for age, education and BP group.

b

Adjusting for education and BP group.

BMI was associated with the prevalence of cognitive impairment in elderly women in Models 1, 2, and 3, while BMI was not associated with cognitive impairment in any multivariate model in elderly men. Each 1-unit increase in BMI was associated with a 5.9% increase in the prevalence of cognitive impairment in elderly women after adjusting for age, educational level, smoking, drinking, physical exercise, BP group, diabetes, and hyperlipidemia in Model 3 (95% CI 1.003–1.119; P = 0.038; Table 4).

Table 4.

Association of BMI and waist circumference with cognitive impairment by sex, according to demographic characteristics and risk factor groups in the multivariate analysis.

Factors Model 1 OR (95% CI) Model 2 OR (95% CI) Model 3 OR (95% CI)
BMI
   Male 0.961 (0.900, 1.025) 0.963 (0.902, 1.028) 0.938 (0.875, 1.005)
   Female 1.058 (1.005, 1.115)* 1.057 (1.003, 1.113)* 1.059 (1.003, 1.119)*
Waist circumference
   Male 0.973 (0.951, 0.997)* 0.975 (0.952, 0.998)* 0.960 (0.935, 0.984)*
   Female 1.015 (0.995, 1.036) 1.015 (0.995, 1.037) 1.015 (0.994, 1.037)

Model 1 analysis adjusted by age and education.

Model 2 analysis adjusted by age, education, smoking, drinking and physical exercise.

Model 3 analysis adjusted age, education, smoking, drinking, physical exercise, BP group, diabetes and hyperlipidemia.

*

Represents P < 0.05.

For elderly men, WC was related to the prevalence of cognitive impairment in Models 1, 2, and 3. Each 1-cm increase in WC was associated with a 4.0% decrease in the prevalence of cognitive impairment after adjusting for age, educational level, smoking, drinking, physical exercise, BP group, diabetes, and hyperlipidemia in Model 3 (95% CI 0.935–0.984; P = 0.002). However, there was no significant association between WC and cognitive impairment in elderly women (Table 4).

This study further explored the relationships between cognitive impairment with sex-specific quartiles of BMI and WC. Compared with the first quartile of BMI, the OR of the third quartile group among elderly women was 1.79 (95% CI 1.05–3.05) after adjusting for age, education, and BP group. For elderly men, the risk of cognitive impairment in the highest WC quartile decreased by 55% when compared with that in the lowest quartile (Table 5).

Table 5.

Association of BMI and waist circumference quartiles with cognitive impairment by sex in the multivariate analysis.

Characteristics References OR (95% CI)
Male Female
BMIa First quartile
   Second quartile 0.91 (0.52, 1.57) 0.94 (0.54, 1.63)
   Third quartile 0.63 (0.35, 1.14) 1.79 (1.05, 3.05)*
   Fourth quartile 0.66 (0.35, 1.23) 1.25 (0.73, 2.14)
WC a First quartile
   Second quartile 0.84 (0.47, 1.48) 1.02 (0.60, 1.75)
   Third quartile 0.64 (0.36, 1.16) 1.41 (0.85, 2.32)
   Fourth quartile 0.45 (0.24, 0.81)** 1.25 (0.73, 2.15)
a

Adjusting for age, education and BP group.

*

represents P < 0.05;

**

represents P < 0.01.

When the interaction term was introduced, the analyses revealed a significant interaction between sex and BMI as well as sex and WC (Table 6).

Table 6.

The interaction analysis between sex and BMI/ WC in multivariate logistic regression analysis.

Variables OR 95% CI P
Model 1a
   Sex 0.152 0.019, 1.185 0.072
   BMI 0.956 0.894, 1.022 0.186
   Sex*BMI 1.093 1.006, 1.187 0.035
Model 2b
   Sex 0.033 0.002, 0.535 0.016
   WC 0.970 0.947, 0.993 0.012
   Sex*WC 1.043 1.011, 1.076 0.008
a

Model 1 was adjusted for age, education, blood pressure groups and interaction terms sex by BMI.

b

Model 2 was adjusted for age, education, blood pressure groups and interaction terms sex by WC.

Discussion

The relationship between obesity and cognitive impairment in old age has been a controversial issue for many years. In the present population-based study, we evaluated the sex differences in the associations of BMI and WC with cognitive impairment in a low-income elderly population in rural China. We found that BMI was related to the prevalence of cognitive impairment in elderly women, not in elderly men; each 1-unit increase in BMI corresponded to a 5.9% increase in cognitive impairment in elderly women. Besides, each 1-cm increase in WC corresponded to a 4.0% decrease in prevalence of cognitive impairment in the fully adjusted model in elderly men. In the age subgroup analysis, the association remained consistent among men aged 60–64 years. However, there were no significant associations between WC and cognitive impairment in elderly women.

Obesity is often recognized as a public health issue worldwide because of its contribution to increased mortality and morbidity from cardiovascular diseases (26). However, the association between BMI and cognitive decline in the elderly is complex and controversial. Most studies have reported that being overweight in later life was associated with a lower risk of cognitive impairment and dementia in the elderly, which supported the “jolly fat” hypothesis of cognitive function (18, 20, 2729). A clinical retrospective cohort study over two decades was conducted in the UK, and almost two million participants aged 40 years and older were included. In that study, being overweight or even obese in middle age and old age was associated with a decreased risk of dementia. Obese individuals (i.e., BMI >40 kg/m2) had a 29% lower (95% CI 22–36%) dementia risk than individuals with a healthy weight, while underweight people (i.e., BMI <20 kg/m2) had a 34% higher (95% CI 29–38%) risk of dementia (30). However, a recent systematic review failed to find a beneficial effect of being overweight on cognitive function in later life (31). Additionally, a few studies have reported that obesity is negatively associated with cognitive function in old age (16, 17). A population-based cross-sectional study in central Spain suggested that overweight and obese elderly adults had poorer neuropsychological performance than elderly adults with normal weight in verbal fluency, delayed-free recall, and immediate logical memory (16). Another population-based study revealed that increased BMI and visceral fat mass were associated with severe cognitive impairment in older men (17). In our study, a high BMI was associated with an increased prevalence of cognitive impairment in elderly women. In contrast, a high BMI appeared to be a protective factor for elderly men, although not to a significant degree, which was partly consistent with results of previous studies (18, 20). A prospective study of community-dwelling Koreans demonstrated that increased obesity, as defined using BMI, over time was associated with better cognitive function in elderly men. However, for elderly women, increased obesity, as defined using WC and waist-to-hip ratio (WHR), over time was associated with cognitive decline (18). The beneficial effects of obesity seemed to be applicable to elderly men and not to elderly women.

WC is a more accurate indicator of abdominal visceral obesity than BMI, percent body fat, and WHR (32). Moreover, abdominal obesity as classified using WC is a component of metabolic syndrome and is generally regarded as harmful to health. Most previous studies have demonstrated that a large WC is a risk factor for both cognitive impairment and dementia in the elderly (13, 16, 3335). A longitudinal community-based study with an 8-year follow-up period revealed that abdominal obesity in late life carried an increased risk of cognitive impairment. Compared with the low WC tertile, the middle and high WC tertiles were associated with 80 and 90% higher incidence rates of cognitive impairment, respectively (13). In China, a hospital-based study found that abdominal obesity as defined by WHR was an independent risk factor for cognitive impairment (OR 1.532; 95% CI 1.037–2.263) (36). In contrast, we found that a large WC was associated with a decreased prevalence in cognitive impairment in elderly men, independent of sociodemographic, lifestyle, and health-related factors. Each 1-cm increase in WC corresponded to 4.0% decrease in prevalence of cognitive impairment in elderly men. Furthermore, results of two Asian population-based studies are consistent with our findings. One population-based study suggested that abdominal obesity (i.e., WC ≥90 cm for men and ≥80 cm for women) might be a protective factor for cognitive function in the elderly (OR 0.72; 95% CI 0.56–0.92) in the rural area of Shenyang, China (37). In addition, a prospective community-dwelling Korean study illustrated that WC had a U-shaped correlation with cognitive function in the elderly, and increased central obesity over time as assessed using WC and WHR was associated with better cognitive function in elderly men (18).

In addition to obesity indicators, other cardiovascular risk factors, including hypertension, diabetes mellitus, hyperlipidemia, and smoking, have been linked with cognitive decline in adults (3840). In our previous studies, a high blood pressure proved to be a risk factor for cognitive impairment (9, 19). However, there was no association between diabetes and cognitive impairment in this population (9, 19). Previous studies have reported that hyperlipidemia is associated with cognitive impairment (41, 42). Several studies suggested both WC and BMI were ideal indicators for hyperlipidemia (43, 44). A cross-sectional study found BMI and WC were comparable to body fat mass in identifying metabolic risk factors including hyperlipidemia (45). In present study, after adjusting for hyperlipidemia and other confounding factors, BMI and WC were associated with cognitive decline in elderly women and men, respectively.

In this study, there were different associations between obesity and cognitive function according to sex. Obesity appears to be protective for cognitive function only in elderly men, not elderly women. Several mechanisms may account for these results. First, female sex is a risk factor for cognitive decline (9). Women are more likely to develop central obesity in this population. Second, testosterone is an important neuroprotective hormone, as it decreases the accumulation of amyloid β-protein and inhibits the hyperphosphorylation of tau (46). Men are likely to maintain more testosterone in body fat, which may prevent cognitive decline (47). Third, in rural China, men tend to obtain higher educational levels, have more social contact, and be less depressed. Therefore, they are more likely to seek cognitive rehabilitation to improve cognitive disorders.

There are several limitations in this study. First, the study population was from a low-income, low-education rural population in northern China; thus, its representation and generalizability are limited. Second, cognitive impairment was evaluated with MMSE scores; therefore, different types of cognitive impairment could not be further diagnosed in the study. Third, other confounding factors, including apolipoprotein E genotype, frailty, and diet, are important factors for cognitive decline but were not assessed in this study because of limited funding. In the future, we plan to conduct a study including physical capability markers. Fourth, this was a cross-sectional study; thus, causal relationships could not be established. A prospective cohort study will be conducted using this study as reference.

Conclusion

A higher WC was positively associated with better cognitive function in low-income elderly men in rural China, whereas a higher BMI was associated with increased cognitive impairment in low-income elderly women in China, independent of sociodemographic, lifestyle, and health-related comorbid factors. The beneficial effects of obesity on cognitive impairment seemed to be applicable to elderly men, not women. Our results suggest weight management of elderly women in rural China may have cognitive benefits. However, randomized controlled trials would be needed to confirm causality.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by the Ethics Committee of Tianjin Medical University General Hospital. The patients/participants provided their written informed consent to participate in this study.

Author Contributions

JW, XN, and YS contributed to the study design, performed data collection, data interpretation, and critical review. JW performed data analysis. DG, XZ, and CZ contributed to drafting of the article. DG, XZ, CZ, QL, JL, QY, and JT performed data collection, case diagnoses, and confirmation of case diagnoses. All authors read, revised, and approved the final version of the paper.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1.GBD 2017 DALYs and HALE Collaborators . Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. (2018) 392:1859–922. 10.1016/S0140-6736(18)32335-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wortmann M. Dementia: a global health priority - highlights from an ADI and World Health Organization report. Alzheimers Res Ther. (2012) 4:40. 10.1186/alzrt143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.World Alzheimer Report 2019 . Attitudes to Dementia. Available online at: https://www.alzint.org/resource/world-alzheimer-report-2019/ (accessed on May 1, 2020).
  • 4.Ding D, Zhao Q, Wu W, Xiao Z, Liang X, Luo J, et al. Prevalence and incidence of dementia in an older Chinese population over two decades: the role of education. Alzheimers Dement. (2020) 16:1650–62. 10.1002/alz.12159 [DOI] [PubMed] [Google Scholar]
  • 5.Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. (2014) 10:1–9. 10.1016/j.jalz.2013.01.012 [DOI] [PubMed] [Google Scholar]
  • 6.Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. (2008) 32:1431–7. 10.1038/ijo.2008.102 [DOI] [PubMed] [Google Scholar]
  • 7.Zhang X, Zhang M, Zhao Z, Huang Z, Deng Q, Li Y, et al. Geographic variation in prevalence of adult obesity in China: results from the 2013-2014 national chronic disease and risk factor surveillance. Ann Intern Med. (2020) 172:291–3. 10.7326/M19-0477 [DOI] [PubMed] [Google Scholar]
  • 8.Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. (2011) 10:819–28. 10.1016/S1474-4422(11)70072-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ren L, Bai L, Wu Y, Ni J, Shi M, Lu H, et al. Prevalence of and risk factors for cognitive impairment among elderly without cardio- and cerebrovascular diseases: a population-based study in rural China. Front Aging Neurosci. (2018) 10:62. 10.3389/fnagi.2018.00062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.West NA, Lirette ST, Cannon VA, Turner ST, Mosley TH, Jr, Windham BG. Adiposity, change in adiposity, and cognitive decline in mid- and late life. J Am Geriatr Soc. (2017) 65:1282–8. 10.1111/jgs.14786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hartanto A, Yong JC, Toh WX. Bidirectional associations between obesity and cognitive function in midlife adults: a longitudinal study. Nutrients. (2019) 11:2343. 10.3390/nu11102343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dye L, Boyle NB, Champ C, Lawton C. The relationship between obesity and cognitive health and decline. Proc Nutr Soc. (2017) 76:443–54. 10.1017/S0029665117002014 [DOI] [PubMed] [Google Scholar]
  • 13.West NA, Haan MN. Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. J Gerontol A Biol Sci Med Sci. (2009) 64:103–9. 10.1093/gerona/gln006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Vidyanti AN, Hardhantyo M, Wiratama BS, Prodjohardjono A, Hu CJ. Obesity is less frequently associated with cognitive impairment in elderly individuals: a cross-sectional study in Yogyakarta, Indonesia. Nutrients. (2020) 12:367. 10.3390/nu12020367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhang J, Tang G, Xie H, Wang B, He M, Fu J, et al. Higher adiposity is associated with slower cognitive decline in hypertensive patients: secondary analysis of the china stroke primary prevention trial. J Am Heart Assoc. (2017) 6:e005561. 10.1161/JAHA.117.005561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Benito-León J, Mitchell AJ, Hernández-Gallego J, Bermejo-Pareja F. Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol. (2013) 20:899–906. 10.1111/ene.12083 [DOI] [PubMed] [Google Scholar]
  • 17.Papachristou E, Ramsay SE, Lennon LT, Papacosta O, Iliffe S, Whincup PH, et al. The relationships between body composition characteristics and cognitive functioning in a population-based sample of older British men. BMC Geriatr. (2015) 15:172. 10.1186/s12877-015-0169-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Han C, Jo SA, Seo JA, Kim BG, Kim NH, Jo I, et al. Adiposity parameters and cognitive function in the elderly: application of “Jolly Fat” hypothesis to cognition. Arch Gerontol Geriatr. (2009) 49:e133–133e138. 10.1016/j.archger.2008.11.005 [DOI] [PubMed] [Google Scholar]
  • 19.Liu W, Wu Y, Bai L, Ni J, Tu J, Liu J, et al. Sex differences in the prevalence of and risk factors for nonvascular cognitive function in rural, low-income elderly in Tianjin, China. Neuroepidemiology. (2018) 51:138–48. 10.1159/000490496 [DOI] [PubMed] [Google Scholar]
  • 20.Zhang L, Li JL, Zhang LL, Guo LL, Li H, Yan W, et al. Relationship between adiposity parameters and cognition: the “fat and jolly” hypothesis in middle-aged and elderly people in China. Medicine. (2019) 98:e14747. 10.1097/MD.0000000000014747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang J, Ning X, Yang L, Tu J, Gu H, Zhan C, et al. Sex differences in trends of incidence and mortality of first-ever stroke in rural Tianjin, China, from 1992 to 2012. Stroke. (2014) 45:1626–31. 10.1161/STROKEAHA.113.003899 [DOI] [PubMed] [Google Scholar]
  • 22.Hu Y, Zhao L, Zhang H, Yu X, Wang Z, Ye Z, et al. Sex Differences in the recurrence rate and risk factors for primary giant cell tumors around the knee in China. Sci Rep. (2016) 6:28173. 10.1038/srep28173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Canadian Task Force on Preventive Health Care. Pottie K, Rahal R, Jaramillo A, Birtwhistle R, Thombs BD. Recommendations on screening for cognitive impairment in older adults. CMAJ. (2016) 188:37–46. 10.1503/cmaj.141165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Nunes B, Silva RD, Cruz VT, Roriz JM, Pais J, Silva MC. Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal. BMC Neurol. (2010) 10:42. 10.1186/1471-2377-10-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Box GEP, Tidwell PW. Transformation of the independent variables. Technometrics. (1962) 4:531–50. [Google Scholar]
  • 26.Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. (2016) 118:1752–70. 10.1161/CIRCRESAHA.115.306883 [DOI] [PubMed] [Google Scholar]
  • 27.Kim S, Kim Y, Park SM. Body mass index and decline of cognitive function. PLoS ONE. (2016) 11:e0148908. 10.1371/journal.pone.0148908 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tikhonoff V, Casiglia E, Guidotti F, Giordano N, Martini B, Mazza A, et al. Body fat and the cognitive pattern: a population-based study. Obesity. (2015) 23:1502–10. 10.1002/oby.21114 [DOI] [PubMed] [Google Scholar]
  • 29.Ghaderpanahi M, Fakhrzadeh H, Sharifi F, Mirarefin M, Badamchizade Z, Larijani B, et al. Association between late-life body mass index, waist circumference, and dementia: Kahrizak Elderly Study. J Am Geriatr Soc. (2012) 60:173–4. 10.1111/j.1532-5415.2011.03751.x [DOI] [PubMed] [Google Scholar]
  • 30.Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. (2015) 3:431–6. 10.1016/S2213-8587(15)00033-9 [DOI] [PubMed] [Google Scholar]
  • 31.Danat IM, Clifford A, Partridge M, Zhou W, Bakre AT, Chen A, et al. Impacts of overweight and obesity in older age on the risk of dementia: a systematic literature review and a meta-analysis. J Alzheimers Dis. (2019) 70:S87–99. 10.3233/JAD-180763 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rankinen T, Kim SY, Pérusse L, Després JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord. (1999) 23:801–9. 10.1038/sj.ijo.0800929 [DOI] [PubMed] [Google Scholar]
  • 33.Masi S, Georgiopoulos G, Khan T, Johnson W, Wong A, Charakida M, et al. Patterns of adiposity, vascular phenotypes and cognitive function in the 1946 British Birth Cohort. BMC Med. (2018) 16:75. 10.1186/s12916-018-1059-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Fergenbaum JH, Bruce S, Lou W, Hanley AJ, Greenwood C, Young TK. Obesity and lowered cognitive performance in a Canadian First Nations population. Obesity. (2009) 17:1957–63. 10.1038/oby.2009.161 [DOI] [PubMed] [Google Scholar]
  • 35.Yao Q, Jiang GX, Zhou ZM, Chen JM, Cheng Q. Metabolic syndrome and mild cognitive impairment: a case-control study among elderly in a Shanghai Suburb. J Alzheimers Dis. (2016) 51:1175–82. 10.3233/JAD-150920 [DOI] [PubMed] [Google Scholar]
  • 36.Hou Q, Guan Y, Yu W, Liu X, Wu L, Xiao M, et al. Associations between obesity and cognitive impairment in the Chinese elderly: an observational study. Clin Interv Aging. (2019) 14:367–73. 10.2147/CIA.S192050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wang X, Luan D, Xin S, Liu Y, Gao Q. Association Between Individual Components of Metabolic Syndrome and Cognitive Function in Northeast Rural China. Am J Alzheimers Dis Other Demen. (2019) 34:507–12. 10.1177/1533317519865428 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lourenco J, Serrano A, Santos-Silva A, Gomes M, Afonso C, Freitas P, et al. Cardiovascular Risk Factors Are Correlated with Low Cognitive Function among Older Adults Across Europe Based on The SHARE Database. Aging Dis. (2018) 9:90–101. 10.14336/AD.2017.0128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Yaffe K, Bahorik AL, Hoang TD, Forrester S, Jacobs DR, Jr, Lewis CE, et al. Cardiovascular risk factors and accelerated cognitive decline in midlife: The CARDIA Study. Neurology. (2020) 95:e839–839e846. 10.1212/WNL.0000000000010078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yaffe K, Vittinghoff E, Hoang T, Matthews K, Golden SH, Zeki Al Hazzouri A. Cardiovascular risk factors across the life course and cognitive decline: a pooled cohort study. Neurology. (2021) 96:e2212–9. 10.1212/WNL.0000000000011747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zhao B, Shang S, Li P, Chen C, Dang L, Jiang Y, et al. The gender- and age- dependent relationships between serum lipids and cognitive impairment: a cross-sectional study in a rural area of Xi'an, China. Lipids Health Dis. (2019) 18:4. 10.1186/s12944-018-0956-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zou Y, Zhu Q, Deng Y, Duan J, Pan L, Tu Q, et al. Vascular risk factors and mild cognitive impairment in the elderly population in Southwest China. Am J Alzheimers Dis Other Demen. (2014) 29:242–7. 10.1177/1533317513517042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zhang P, Sun X, Jin H, Zhang FL, Guo ZN, Yang Y. Association between obesity type and common vascular and metabolic diseases: a cross-sectional study. Front Endocrinol. (2019) 10:900. 10.3389/fendo.2019.00900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lee BJ, Yim MH. Comparison of anthropometric and body composition indices in the identification of metabolic risk factors. Sci Rep. (2021) 11:9931. 10.1038/s41598-021-89422-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes. (2006) 30:475–83. 10.1038/sj.ijo.0803144 [DOI] [PubMed] [Google Scholar]
  • 46.Papasozomenos SC. The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease. Proc Natl Acad Sci USA. (1997) 94:6612–7. 10.1073/pnas.94.13.6612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. (2002) 87:5001–7. 10.1210/jc.2002-020419 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Neurology are provided here courtesy of Frontiers Media SA

RESOURCES